SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 101 filers reported holding SPERO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $499,512 | -11.9% | 412,707 | +5.6% | 0.00% | – |
| Q2 2023 | $566,667 | +15.7% | 390,805 | +15.7% | 0.00% | – |
| Q1 2023 | $489,891 | +109987.9% | 337,856 | +31.3% | 0.00% | – |
| Q4 2022 | $445 | -99.9% | 257,284 | -11.4% | 0.00% | – |
| Q3 2022 | $580,000 | +169.8% | 290,258 | 0.0% | 0.00% | – |
| Q2 2022 | $215,000 | -94.8% | 290,258 | -38.4% | 0.00% | -100.0% |
| Q1 2022 | $4,099,000 | -44.0% | 471,189 | +3.1% | 0.00% | 0.0% |
| Q4 2021 | $7,319,000 | -10.6% | 457,184 | +2.8% | 0.00% | 0.0% |
| Q3 2021 | $8,190,000 | +41.8% | 444,914 | +7.5% | 0.00% | 0.0% |
| Q2 2021 | $5,776,000 | +7.9% | 413,761 | +13.8% | 0.00% | 0.0% |
| Q1 2021 | $5,352,000 | -22.9% | 363,611 | +1.5% | 0.00% | 0.0% |
| Q4 2020 | $6,944,000 | +212.1% | 358,148 | +79.6% | 0.00% | – |
| Q3 2020 | $2,225,000 | -16.4% | 199,429 | +1.4% | 0.00% | -100.0% |
| Q2 2020 | $2,661,000 | +112.2% | 196,700 | +26.7% | 0.00% | – |
| Q1 2020 | $1,254,000 | -45.4% | 155,224 | -35.0% | 0.00% | – |
| Q4 2019 | $2,296,000 | +85.6% | 238,904 | +104.6% | 0.00% | – |
| Q3 2019 | $1,237,000 | -6.3% | 116,782 | +1.8% | 0.00% | – |
| Q2 2019 | $1,320,000 | +9.3% | 114,717 | +21.6% | 0.00% | – |
| Q1 2019 | $1,208,000 | +7.1% | 94,341 | -48.6% | 0.00% | – |
| Q4 2018 | $1,128,000 | +22.1% | 183,684 | +108.8% | 0.00% | – |
| Q3 2018 | $924,000 | +17.9% | 87,966 | +64.5% | 0.00% | – |
| Q2 2018 | $784,000 | +170.3% | 53,490 | +162.3% | 0.00% | – |
| Q1 2018 | $290,000 | – | 20,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,353,303 | $1,637,497 | 13.93% |
| Anson Funds Management LP | 4,159,572 | $5,033,082 | 1.01% |
| OUP Management Co., LLC | 249,070 | $301,375 | 0.68% |
| Atlas Venture Life Science Advisors, LLC | 1,013,438 | $1,226,260 | 0.19% |
| Murchinson Ltd. | 862,700 | $1,043,867 | 0.13% |
| Alphabet Inc. | 889,979 | $1,076,874 | 0.07% |
| AWM Investment Company, Inc. | 333,400 | $403,414 | 0.06% |
| DAFNA Capital Management LLC | 125,000 | $151,250 | 0.05% |
| Novo Holdings A/S | 468,902 | $567,371 | 0.04% |
| XTX Topco Ltd | 58,368 | $70,625 | 0.01% |